We are live on ! Find out more
ANTX icon

AN2 Therapeutics

38 hedge funds and large institutions have $165M invested in AN2 Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

99% more capital inflows, than outflows

Capital inflows: $2.49M | Capital outflows: $1.25M

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

6% more funds holding

Funds holding: 36 → 38 (+2)

0.57% more ownership

Funds ownership: 48.39% → 48.95% (+0.57%)

Holders
38
Holders Change
+2
Holders Change %
+5.56%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
16
Reduced
12
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ANTX Hedge Fund Activity: Q3 2022 in Review

38 of the 5,834 institutional investors tracked by Wall St. Rank reported a position in AN2 Therapeutics (ANTX) for Q3 2022, worth a combined $165M — up 128% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ANTX positions and 1 closed out — a net gain of 2 holders — while 16 added to existing stakes and 12 trimmed.

The largest buyer was Avidity Partners Management, adding an estimated $633K. The largest seller was Woodline Partners, cutting an estimated $363K.

  • 38 institutional investors held AN2 Therapeutics (ANTX) as of Q3 2022, up from 36 in Q2 2022.
  • Funds reported $165M of AN2 Therapeutics stock for Q3 2022, up 128% quarter-over-quarter.
  • 3 funds opened new AN2 Therapeutics positions in Q3 2022 and 1 closed out, a net change of +2 holders.
  • The largest AN2 Therapeutics buyer in Q3 2022 was Avidity Partners Management, an estimated $633K added.
  • The largest AN2 Therapeutics seller in Q3 2022 was Woodline Partners, an estimated $363K sold.

Based on aggregated 13F filings for Q3 2022.